NPI: 1407945629 · SANTA MONICA, CA 90401 · Community Health Clinic/Center · NPI assigned 10/12/2006
Authorized official PAHL, LINDA controls 20+ related entities in our dataset. Read more
| Authorized Official | PAHL, LINDA (CFO) |
| NPI Enumeration Date | 10/12/2006 |
Other providers sharing the same authorized official: PAHL, LINDA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 26,667 | $1.10M |
| 2019 | 11,896 | $546K |
| 2020 | 9,251 | $380K |
| 2021 | 13,105 | $630K |
| 2022 | 9,213 | $448K |
| 2023 | 11,052 | $681K |
| 2024 | 9,809 | $654K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 5,501 | 4,979 | $731K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2,911 | 2,746 | $617K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1,755 | 1,687 | $552K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 4,483 | 4,258 | $439K |
| S4993 | Contraceptive pills for birth control | 3,190 | 3,181 | $372K |
| J3490 | Unclassified drugs | 10,893 | 9,239 | $356K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1,636 | 1,605 | $313K |
| 87806 | 7,409 | 5,613 | $188K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 2,705 | 2,637 | $184K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 350 | 350 | $137K |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 79 | 79 | $68K |
| 58300 | 676 | 331 | $62K | |
| 99401 | 3,233 | 3,153 | $62K | |
| A4267 | Contraceptive supply, condom, male, each | 7,186 | 7,097 | $51K |
| 99201 | 360 | 355 | $45K | |
| S5000 | Prescription drug, generic | 4,788 | 4,544 | $30K |
| 81025 | 8,500 | 8,168 | $27K | |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | 2,099 | 2,099 | $27K |
| 58301 | 631 | 316 | $21K | |
| 90651 | 71 | 71 | $20K | |
| 83986 | 7,531 | 6,062 | $20K | |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | 5,151 | 4,960 | $19K |
| J7303 | Contraceptive supply, hormone containing vaginal ring, each | 225 | 224 | $19K |
| 99000 | 4,485 | 4,440 | $16K | |
| 99402 | 488 | 485 | $16K | |
| 11981 | 67 | 67 | $15K | |
| 86703 | 941 | 718 | $10K | |
| 81002 | 2,269 | 2,197 | $4K | |
| 57454 | 53 | 27 | $3K | |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | 808 | 794 | $3K |
| 76857 | 41 | 41 | $2K | |
| 11976 | 24 | 12 | $1K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 33 | 33 | $782.66 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 33 | 32 | $773.79 |
| 86592 | 135 | 135 | $447.59 | |
| 82120 | 91 | 87 | $328.10 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 57 | 39 | $298.01 |
| 87210 | 90 | 86 | $297.21 | |
| S5001 | Prescription drug, brand name | 15 | 15 | $188.00 |